Eva‐Lotte Lindstedt

Structure of the PPARα and -γ Ligand Binding Domain in Complex with AZ 242; Ligand Selectivity and Agonist Activation in the PPAR Family

Philippe Cronet, Jens Petersen, R.H.A. Folmer et al. · Structure · 2001 · 327 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque

Imran Rashid, Ghassan J. Maghzal, Yung‐Chih Chen et al. · European Heart Journal · 2018 · 120 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17

Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results

Carolyn S.P. Lam, Lars H. Lund, Sanjiv J. Shah et al. · Journal of Cardiac Failure · 2023 · 64 citations · Full text

Medicine, Cardiology, Pharmacology +17

Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction

Karin Nelander, Maria Lagerström‐Fermér, Carl Amilon et al. · Clinical and Translational Science · 2020 · 45 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands

Anna Y. Belorusova, Emma Evertsson, Daniel Hovdal et al. · Communications Biology · 2019 · 41 citations · Full text

Medicine, Biochemistry, Pharmacology +16